$332 Million is the total value of BAXTER BROS INC's 117 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NSC | Norfolk Southern | $3,022,000 | +8.7% | 24,828 | 0.0% | 0.91% | +4.7% | |
| Berkshire Hathaway | $2,547,000 | +2.0% | 10 | 0.0% | 0.77% | -1.8% | ||
| CNI | Canadian Nat. Railway | $1,426,000 | +9.6% | 17,600 | 0.0% | 0.43% | +5.4% | |
| ETN | Eaton Corp | $1,145,000 | +4.9% | 14,712 | 0.0% | 0.34% | +1.2% | |
| MO | Philip Morris Int'l | $1,056,000 | +4.0% | 8,991 | 0.0% | 0.32% | +0.3% | |
| MDT | Medtronic PLC F | $934,000 | +10.1% | 10,524 | 0.0% | 0.28% | +6.0% | |
| UBSH | Markel Corp Holding Co | $777,000 | 0.0% | 796 | 0.0% | 0.23% | -3.7% | |
| SYK | Stryker | $657,000 | +5.3% | 4,737 | 0.0% | 0.20% | +1.5% | |
| GIS | General Mills | $497,000 | -6.2% | 8,974 | 0.0% | 0.15% | -9.6% | |
| EXPD | Expeditors Int'l Of Wa | $474,000 | -0.2% | 8,400 | 0.0% | 0.14% | -4.0% | |
| IMGN | Immunogen Inc | $412,000 | +83.9% | 58,000 | 0.0% | 0.12% | +77.1% | |
| DOW | Dow Chemical | $378,000 | -0.8% | 5,990 | 0.0% | 0.11% | -4.2% | |
| DE | Deere And Co | $297,000 | +13.8% | 2,400 | 0.0% | 0.09% | +8.5% | |
| SMG | Scotts Miracle Grow | $281,000 | -4.1% | 3,140 | 0.0% | 0.08% | -7.6% | |
| UAL | United Continental Holdings In | $268,000 | +6.3% | 3,565 | 0.0% | 0.08% | +2.5% | |
| SJM | Jm Smucker Co | $268,000 | -9.8% | 2,268 | 0.0% | 0.08% | -12.9% | |
| DALRQ | Delta Air Lines Inc | $262,000 | +17.0% | 4,870 | 0.0% | 0.08% | +12.9% | |
| SHW | Sherwin Williams | $253,000 | +13.5% | 720 | 0.0% | 0.08% | +8.6% | |
| ABT | Abbott Labs | $244,000 | +9.4% | 5,021 | 0.0% | 0.07% | +4.3% | |
| United Healthcare | $238,000 | +13.3% | 1,281 | 0.0% | 0.07% | +9.1% | ||
| SO | Southern Co. | $235,000 | -3.7% | 4,900 | 0.0% | 0.07% | -6.6% | |
| MDLZ | Mondelez Int'l Inc A | $227,000 | +0.4% | 5,247 | 0.0% | 0.07% | -4.2% | |
| CLX | Clorox Company | $201,000 | -1.0% | 1,508 | 0.0% | 0.06% | -3.2% | |
| ARRY | Array Biopharmaceutical Inc | $119,000 | -6.3% | 14,200 | 0.0% | 0.04% | -10.0% | |
| PPHM | Peregrine Pharma Inc | $92,000 | -6.1% | 150,500 | 0.0% | 0.03% | -9.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-01
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Microsoft | 41 | Q3 2023 | 9.2% |
| Intuit Inc | 41 | Q3 2023 | 6.3% |
| Visa | 41 | Q3 2023 | 5.8% |
| Union Pacific | 41 | Q3 2023 | 4.5% |
| Comcast A | 41 | Q3 2023 | 4.3% |
| Disney | 41 | Q3 2023 | 3.7% |
| Wells Fargo & Co. | 41 | Q3 2023 | 4.1% |
| Qualcomm | 41 | Q3 2023 | 4.0% |
| Procter & Gamble | 41 | Q3 2023 | 3.8% |
| Intel | 41 | Q3 2023 | 3.5% |
View BAXTER BROS INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-05-17 |
| 13F-HR/A | 2024-05-17 |
| 13F-HR | 2024-04-29 |
| 13F-HR | 2024-02-06 |
| 13F-HR | 2023-10-23 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-07-25 |
View BAXTER BROS INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.